MBRX

MOLECULIN BIOTECH INC

MBRX·60855D408·US·Common Stock·Healthcare - Biotechnology-13D/G

MBRX (MOLECULIN BIOTECH INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($74,033), VANGUARD CAPITAL MANAGEMENT LLC ($31,760), VANGUARD FIDUCIARY TRUST CO ($13,905). Net institutional sentiment: Mixed.

12
Holders
Avg rating(2 Elite)
$138,936
Total Value
58% (15)
Fund Consensus
7 buying - 5 selling
MBRXSmart Money Verdict
View all
Held by 12 funds
2 elite
Who's Trading
ActivistARArmistice Capital, LLC5.0%Aug 14, 2025
InsiderKVKLEMP WALTER VBuy $250KJun 23, 2025
InsiderFPFoster Jonathan P.Buy $100KJun 23, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
32,329(+113.6%)$74,0330.0%-17.44%
23
New
13,869$31,7600.0%+0.44%
30
New
6,072$13,9050.0%+0.44%
27
Increased
4,421(+1928.0%)$10,1240.0%-1.80%
19
Decreased
3,409(-41.9%)$7,8070.0%-31.33%
0
Decreased
491(-0.8%)$1,1240.0%-31.33%
0
Unchanged
36$830.0%-31.33%
0
New
24$550.0%+0.44%
17
New
13,739$310.0%+0.44%
15
New
3$70.0%+0.44%
17
Unchanged
2$50.0%-31.33%
0
Unchanged
1$20.0%-31.33%
0
Exited
0(-100.0%)$109,5110.0%-31.63%
0
Exited
0(-100.0%)$74,6400.0%-31.63%
0
Exited
0(-100.0%)$1190.0%-31.63%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used